Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Vsee Health (VSEE) Shares Outstanding (2022 - 2025)

Vsee Health filings provide 4 years of Shares Outstanding readings, the most recent being $33.2 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 103.67% to $33.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $33.2 million, a 103.67% increase, with the full-year FY2025 number at $33.2 million, up 103.67% from a year prior.
  • Shares Outstanding hit $33.2 million in Q4 2025 for Vsee Health, up from $17.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $33.2 million in Q4 2025 to a low of $6158.0 in Q1 2025.
  • Median Shares Outstanding over the past 4 years was $4.6 million (2023), compared with a mean of $9.2 million.
  • Biggest five-year swings in Shares Outstanding: soared 1837.84% in 2023 and later plummeted 97.84% in 2025.
  • Vsee Health's Shares Outstanding stood at $239424.0 in 2022, then soared by 1837.84% to $4.6 million in 2023, then surged by 251.26% to $16.3 million in 2024, then soared by 103.67% to $33.2 million in 2025.
  • The last three reported values for Shares Outstanding were $33.2 million (Q4 2025), $17.0 million (Q3 2025), and $16.4 million (Q2 2025) per Business Quant data.